Hearing Loss Trial, Recruiting NCT07557771 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07557771
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

Normal Hearing Group

  • People who have given voluntary written consent before any screening takes place (or whose legal representative has done so)
  • People who are at least 18 years old at the time of signing the consent form
  • People whose hearing test results show sound is heard at normal levels (at or below 15dB) across all tested frequencies, with no difference between air and bone hearing, and a normal eardrum pressure test result (called Jerger Type A)

Conductive Hearing Loss Group

  • People who have given voluntary written consent before any screening takes place (or whose legal representative has done so)
  • People who are at least 18 years old at the time of signing the consent form
  • People whose bone-conduction hearing test shows hearing at or below 20dB across all frequencies, with some exceptions allowed for age-related hearing loss in higher frequencies or a specific dip in hearing around 2kHz, and where there is a measurable gap between air and bone hearing at one or more frequencies

Cochlear Implant Recipients Group

  • People who have given voluntary written consent before any screening takes place (or whose legal representative has done so)
  • People who are at least 18 years old at the time of signing the consent form
  • People whose ear is already planned for cochlear implant surgery by their ear, nose, and throat surgeon
  • People whose eardrum pressure test result is normal (Jerger Type A)

Who may not be able to join:

Normal Hearing Group

  • People with a significant history of middle ear disease
  • People who have had middle ear surgery in the past
  • People whose ear examination shows a hole in the eardrum or fluid behind the eardrum
  • People with a severe outer ear infection or a blocked ear canal
  • People currently taking part in another clinical trial involving an experimental medicine or device

Conductive Hearing Loss Group

  • People who have had middle ear surgery in the past
  • People whose ear examination shows a hole in the eardrum or fluid behind the eardrum
  • People whose ear shows signs of growths, cysts, or a condition called cholesteatoma (a skin growth in the middle ear)
  • People with a severe outer ear infection or a blocked ear canal
  • People currently taking part in another clinical trial involving an experimental medicine or device

Cochlear Implant Recipients Group

  • People whose ear has a significant history of middle ear disease
  • People whose ear has had middle ear surgery in the past
  • People whose ear examination shows a hole in the eardrum or fluid behind the eardrum
  • People with a severe outer ear infection or a blocked ear canal

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 July 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Wideband Absorbance as measured with Wideband Tympanometry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov